Olaparib-induced cutaneous vasculitis in a patient with recurrent ovarian cancer
Eur J Dermatol
.
2022 Sep 1;32(5):655-656.
doi: 10.1684/ejd.2022.4343.
Authors
Maiko Fukui
1
,
Ken Shiraishi
1
,
Satoshi Yoshida
1
,
Kazuki Yatsuzuka
1
,
Takashi Matsumoto
2
,
Koji Sayama
1
Affiliations
1
Department of Dermatology, Ehime University Graduate School of Medicine, Toon, Ehime, Japan
2
Department of Obstetrics & Gynecology, Ehime University Graduate School of Medicine, Toon, Ehime, Japan
PMID:
36468741
DOI:
10.1684/ejd.2022.4343
No abstract available
MeSH terms
Chronic Disease
Female
Humans
Ovarian Neoplasms* / drug therapy
Phthalazines / adverse effects
Piperazines / adverse effects
Recurrence
Vasculitis*
Substances
olaparib
Phthalazines
Piperazines